psoriasisFDA Issues New Health Advisory For Psoriasis Drug Raptiva
The Food and Drug Administration has just issued a health advisory in response to reports of deadly brain infections in people who use the psoriasis drug Raptiva. There have been three confirmed cases and one possible case of progressive multifocal leukoencephalopathy (PML) in people taking Raptiva. Of those four people, three are now dead. All patients has been treated with Raptiva for at least three years.
Enbrel Linked to Deadly Infections, Cancer in Children
The arthritis and skin disorder drug Enbrel has caused deadly infections and in some cases cancers in children who use the drug, federal regulators said. Enbrel’s maker, Amgen Inc., wants the drug approved for use in children suffering from psoriasis, a painful disease that causes red scales to grow on the skin. Enbrel is already approved to treat psoriasis and rheumatoid arthritis in adults and juvenile arthritis in children. However, FDA scientists, citing reports of dangerous side effects in children …
FDA Investigating Arthritis Drugs’ Possible Link to Cancer in Children
The Food and Drug Administration is looking into whether four drugs used to treat rheumatoid arthritis and other immune system diseases might increase the risk of cancer in children. One of the drugs being investigated is Remicade, which treats Crohn’s disease (inflammation of the bowel) in children. Remicade is made by Johnson & Johnson and is sold in Europe by Schering-Plough. The other drugs involved in the FDA investigation are Enbrel, sold by Amgen and Wyeth; Humira, sold by Abbott …
facebook
rss
twitter